Fahrleitner-Pammer, A; Piswanger-Solkner, C; Obermayer-Pietsch, B; Prenner, G; Tscheliessnigg, KH; Dobnig, H.
Intravenous Ibandronate effectively prevents bone loss and minimizes fracture risk in patients following cardiac transplantation: A prospective randomized placebo controlled study
BONE. 2006; 39(5):S24-S25.-American Endocrine Society; June 2006; Toronto Canada.
[Oral Communication]
Web of Science